Review
doi: 10.7861/clinmedicine.1-6-472.
Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trials
Affiliations
- PMID: 11792088
- PMCID: PMC4953875
- DOI: 10.7861/clinmedicine.1-6-472
Item in Clipboard
Review
Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trials
Clin Med (Lond).
2001 Nov-Dec.
Abstract
Diabetes markedly increases the risk of coronary artery disease and death, but is underrecognised as a cardiovascular risk factor, despite the existence of effective treatments. Because patients with diabetes are at high risk for coronary disease, they have more to gain from prevention. There is evidence from clinical trials that select cardiovascular therapies may work better in diabetes, beyond their expected benefit, and may prevent diabetes itself.
Similar articles
-
Prevention of type 2 diabetes.Curr Diab Rep. 2003 Jun;3(3):235-41. doi: 10.1007/s11892-003-0070-5. Curr Diab Rep. 2003. PMID: 12762972 Review.
-
[Screening and management of coronary artery disease in diabetic patients].Tunis Med. 2006 Oct;84(10):670-6. Tunis Med. 2006. PMID: 17193866 Review. French.
-
Diabetes: a driver for heart failure.Heart. 2011 May;97(9):774-80. doi: 10.1136/hrt.2009.183624. Heart. 2011. PMID: 21474618 Review. No abstract available.
-
[Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].Ned Tijdschr Geneeskd. 1999 Jun 5;143(23):1197-201. Ned Tijdschr Geneeskd. 1999. PMID: 10389533 Review. Dutch.
-
Pharmacological treatment and prevention of heart failure in the diabetic patient.Rev Cardiovasc Med. 2004 Winter;5(1):1-8. Rev Cardiovasc Med. 2004. PMID: 15029109 Review.
Cited by
-
Can blood glucose value really be referred to as a metabolic parameter?Rev Endocr Metab Disord. 2019 Jun;20(2):151-160. doi: 10.1007/s11154-019-09504-0. Rev Endocr Metab Disord. 2019. PMID: 31089886 Free PMC article. Review.
-
Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases.Acta Pharmacol Sin. 2016 Apr;37(4):425-43. doi: 10.1038/aps.2015.145. Epub 2016 Feb 1. Acta Pharmacol Sin. 2016. PMID: 26838072 Free PMC article. Review.
-
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.Can J Cardiol. 2006 Sep;22(11):913-27. doi: 10.1016/s0828-282x(06)70310-5. Can J Cardiol. 2006. PMID: 16971976 Free PMC article.
-
Roles and Therapeutic Implications of Endoplasmic Reticulum Stress and Oxidative Stress in Cardiovascular Diseases.Antioxidants (Basel). 2021 Jul 22;10(8):1167. doi: 10.3390/antiox10081167. Antioxidants (Basel). 2021. PMID: 34439415 Free PMC article. Review.
-
Oral antidiabetic agents: current role in type 2 diabetes mellitus.Drugs. 2005;65(3):385-411. doi: 10.2165/00003495-200565030-00005. Drugs. 2005. PMID: 15669880 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
